Tag Archives: biib

Valeant Subpoenaed By Federal Prosecutors On Pricing

Valeant Pharmaceuticals (VRX) late Wednesday said it has received subpoenas from U.S. Attorneys in Massachusetts and the Southern District of New York related to drug pricing and how it helps patients pay for drugs. It comes as Valeant and a slew of biotechs such as Biogen (BIIB), Gilead Sciences (GILD), Amgen (AMGN) and Celgene (CELG). Valeant said in a statement: “Most of the materials requested by the subpoenas relate to documents with respect

Yahoo, Apple Supplier Top 5 Big-Cap Tech Losers

Since the Nasdaq peaked on July 20, the tech-heavy index has fallen 7.8%. But many tech stock have been much worse. Yahoo (YHOO) — thanks Alibaba (BABA)! — along with Biogen (BIIB) and Apple (AAPL) supplier Qorvo (QRVO) are among the S&P 500’s 5 biggest tech and biotech losers. Apple itself is not one of the biggest S&P 500 tech losers, falling “only” 13.5% since July 20. But Apple, as the biggest cap of all, certainly helped drive Nasdaq and

IBD 50’s 5 Top Drug Stocks: Active In R&D And M&A

Top-rated drugmakers such as Valeant Pharmaceuticals International (VRX) and Celgene (CELG) have been busy in the lab and on Wall Street, taking part in big merger deals. Today’s IBD 50 list features five top-rated drugmakers. In addition to Valeant and Celgene, the list includes Regeneron Pharmaceuticals (REGN), Lannett (LCI) and Allergan (AGN). On Friday Biogen Idec (BIIB) priced $6 billion of senior notes, a day after Gilead Sciences (GILD)